ArticleHaematologica2026

GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study.

Richard F Schlenk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.